Naringenin ameliorates atopic dermatitis by inhibiting inflammation and enhancing immunity through the JAK2/STAT3 pathway
出版年份 2023 全文链接
标题
Naringenin ameliorates atopic dermatitis by inhibiting inflammation and enhancing immunity through the JAK2/STAT3 pathway
作者
关键词
-
出版物
Genes & Genomics
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-14
DOI
10.1007/s13258-023-01457-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent
- (2022) Abdur Rauf et al. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
- Viola yedoensis Makino formula alleviates DNCB-induced atopic dermatitis by activating JAK2/STAT3 signaling pathway and promoting M2 macrophages polarization
- (2022) Hairong Zeng et al. PHYTOMEDICINE
- The JAK/STAT Pathway and Its Selective Inhibition in the Treatment of Atopic Dermatitis: A Systematic Review
- (2022) Aikaterini Tsiogka et al. Journal of Clinical Medicine
- Naringenin: A potential flavonoid phytochemical for cancer therapy
- (2022) Mahzad Motallebi et al. LIFE SCIENCES
- Novel synthesis naringenin-benzyl piperazine derivatives prevent glioblastoma invasion by inhibiting the hypoxia-induced IL6/JAK2/STAT3 axis and activating caspase-dependent apoptosis
- (2022) Ömer Zaim et al. BIOORGANIC CHEMISTRY
- Anti-Inflammatory Effects Exerted by 14-Methoxyalternate C from Antarctic Fungal Strain Pleosporales sp. SF-7343 via the Regulation of NF-κB and JAK2/STAT3 in HaCaT Human Keratinocytes
- (2022) Linsha Dong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Natural products in drug discovery: advances and opportunities
- (2021) Atanas G. Atanasov et al. NATURE REVIEWS DRUG DISCOVERY
- Protective effects of natural products against drug-induced nephrotoxicity: a review in recent years
- (2021) Chen Gao et al. FOOD AND CHEMICAL TOXICOLOGY
- Molecular Mechanisms of Atopic Dermatitis Pathogenesis
- (2021) Jowita Sroka-Tomaszewska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Qingxue jiedu formulation ameliorated DNFB-induced atopic dermatitis by inhibiting STAT3/MAPK/NF-κB signaling pathways
- (2021) Xin Xiong et al. JOURNAL OF ETHNOPHARMACOLOGY
- A comprehensive review of natural products against atopic dermatitis: Flavonoids, alkaloids, terpenes, glycosides and other compounds
- (2021) Shi Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- Update on the Pathogenesis and Therapy of Atopic Dermatitis
- (2021) Huaguo Li et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Naringenin prevents pregnancy‐induced hypertension via suppression of JAK/STAT3 signalling pathway in mice
- (2021) Bide Duan et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors
- (2021) Chisa Nakashima et al. ALLERGOLOGY INTERNATIONAL
- Atopic Dermatitis: Identification and Management of Complicating Factors
- (2020) Risa Tamagawa-Mineoka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Shen-Ling-Bai-Zhu-San Improves Dextran Sodium Sulfate-Induced Colitis by Inhibiting Caspase-1/Caspase-11-Mediated Pyroptosis
- (2020) Limin Chao et al. Frontiers in Pharmacology
- Atopic dermatitis
- (2020) Sinéad M Langan et al. LANCET
- New treatments in atopic dermatitis
- (2020) Neha Puar et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- CYT387, a Novel JAK2 Inhibitor, Suppresses IL-13-Induced Epidermal Barrier Dysfunction Via miR-143 Targeting IL-13Rα1 and STAT3
- (2020) Yan Zu et al. BIOCHEMICAL GENETICS
- Cellulose microsponges based gel of naringenin for atopic dermatitis: Design, optimization, in vitro and in vivo investigation
- (2020) Ruchika L. Nagula et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Comorbidities and the impact of atopic dermatitis
- (2019) Jonathan I. Silverberg ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Mast Cells and Sensory Nerves Contribute to Neurogenic Inflammation and Pruritus in Chronic Skin Inflammation
- (2019) Hanna Siiskonen et al. Frontiers in Cellular Neuroscience
- Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection
- (2019) Anna B. Fishbein et al. Journal of Allergy and Clinical Immunology-In Practice
- Naringenin attenuates nonalocholic fatty liver disease by downregulating NLRP3/NF‐κB pathway in mice
- (2019) Qinyu Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- (2019) Michael D. Howell et al. Frontiers in Immunology
- Osteopontin attenuates inflammation via JAK2/STAT1 pathway in hyperglycemic rats after intracerebral hemorrhage
- (2018) Lei Gong et al. NEUROPHARMACOLOGY
- Immunotherapeutic potential of Codonopsis clematidea and naringenin against visceral leishmaniasis
- (2018) Gurpreet Kaur et al. BIOMEDICINE & PHARMACOTHERAPY
- Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice
- (2018) Wenyu Jin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- New and emerging targeted systemic therapies: a new era for atopic dermatitis
- (2017) Dylan E. Lee et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Naringenin ameliorates skin inflammation and accelerates phenotypic reprogramming from M1 to M2 macrophage polarization in atopic dermatitis NC/Nga mouse model
- (2016) Vengadeshprabhu Karuppagounder et al. EXPERIMENTAL DERMATOLOGY
- TSLP Down-Regulates S100A7 and ß-Defensin 2 Via the JAK2/STAT3-Dependent Mechanism
- (2016) Hana Lee et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis
- (2013) Mayte Suárez-Fariñas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The inhibitory effect of naringenin on atopic dermatitis induced by DNFB in NC/Nga mice
- (2013) Tae-Ho Kim et al. LIFE SCIENCES
- Botanicals in Dermatology
- (2010) Juliane Reuter et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Atopic Dermatitis
- (2010) Thomas Bieber Annals of Dermatology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started